SVG Sprites


Press Release 06.08.2020

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on the news that AstraZeneca approached Gilead about a potential merger:

“Mergers and consolidation in the pharmaceutical industry is bad news for patients, and could prove even more harmful as demand for affordable COVID treatments and vaccines is bound to increase. Drug corporations already have monopoly control to charge patients inflated prices for prescription drugs in the past few years. Corporations like AstraZeneca and Gilead have historically used their monopoly power to price-gouge patents for necessary medicines, charging sometimes tens of thousands of dollars for a single treatment. “

LDPN In the News 06.04.2020

Column: For God’s sake, Mr. President, don’t inject yourself with insulin

LA Times – 6/4/20

“This move is another political stunt from a president worried about his poll numbers with seniors as his broken campaign promises keep stacking up,” said Margarida Jorge, national campaign director for the advocacy group Lower Drug Prices Now.

“Instead of tweaks and one-off proposals for political gain, we need to overhaul the system that gives drug corporations monopoly control over prices, and instead put in place fair rules that ensure access and affordability for everyone,” she said.

LDPN In the News 06.02.2020

Coronavirus Treatments and Vaccines Will Only Work if They Are Affordable | Opinion

Newsweek – 6/2/20

OPED by Cong. Jan Schakowsky (D-IL) and Cong. Francis Rooney (R-FL)

Over the past decade, almost every new medication brought to market was paid for by a hefty investment from taxpayer dollars. Each of these drugs was developed in the interest of a greater public good: to alleviate pain, improve health and save lives. However, accountability for public funding has not prevented pharmaceutical corporations from hiking up prices on new and existing drugs for patients, increasing the cost of prescription drugs up to 10 percent every year.

Press Release 05.28.2020

Vaccine Czar Should Be Subject to Conflict of Interest Code, Groups Say in Ethics Complaint

WASHINGTON, D.C. – President Donald Trump’s vaccine czar – who has extensive ties to the pharmaceutical industry – should be subject to conflict of interest and disclosure rules, Public Citizen and Lower Drug Prices Now said in a complaint filed today.

Press Release 05.28.2020

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on the news that the Vice President’s Chief of Staff, Marc Short, owns stock in companies receiving taxpayer funding for COVID vaccines:

“At this point, we have to assume that conflicts of interest are a prerequisite to working in the Trump administration,” said Margarida Jorge, national campaign director for Lower Drug Prices Now. “The Vice President’s Chief of Staff holds stock in the very prescription drug corporations receiving taxpayer funding for coronavirus treatments.”

LDPN In the News 05.28.2020

Maine Beacon

Maine Beacon podcast interviewed campaign director Margarida Jorge LDPN: The grassroots campaign to stop drug corporations from profiteering off the pandemic (podcast rebroadcast on 6 local radio stations).

LDPN In the News 05.28.2020

Watchdog groups want Trump’s coronavirus vaccine czar to disclose all pharma ties

The Hill – 5/28/20 

“According to an ethics complaint filed with the Department of Health and Human Services Inspector General by Public Citizen and the advocacy group Lower Drug Prices Now, Slaoui should be considered a government employee.”

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles